Global In-Vitro Diagnostics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global In-Vitro Diagnostics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report, we counted In-Vitro Diagnostics reagent.
In-Vitro Diagnostics report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global In-Vitro Diagnostics market is projected to reach US$ 130080 million in 2033, increasing from US$ 105140 million in 2022, with the CAGR of 5.0% during the period of 2023 to 2033. Demand from Diabetes and Infectious Diseases are the major drivers for the industry.
The concentration of the market is relatively high, and the top 10 companies include Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Becton Dickinson, BioMerieux, Sysmex, Hologic, Ortho Clinical Diagnostics, they occupied about 70% of whole market. North America dominates the market which occupied 41.39% of the whole market. Europe, continuing healthcare reforms, will increase the demand. China is going to be a major player in the future, who occupied 15.74% of the whole market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global In-Vitro Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Roche
Abbott
Danaher
Siemens Healthineers
Thermo Fisher Scientific
Sysmex
BioMerieux
Ortho Clinical Diagnostics
Becton Dickinson
Bio-Rad Laboratories
Hologic
LifeScan
Qiagen
Wuhan Easy Diagnosis
Wondfo
KHB
Hotgen
Mindray
Sinocare
Getein Biotech
Segment by Type
Tissue Diagnostics
Professional Diagnostic
Molecular Diagnostic
Diabetes Monitoring
Other
Diabetes
Infectious Diseases
Oncology
Cardiology
HIV
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the In-Vitro Diagnostics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, In-Vitro Diagnostics introduction, etc. In-Vitro Diagnostics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of In-Vitro Diagnostics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
In-Vitro Diagnostics report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global In-Vitro Diagnostics market is projected to reach US$ 130080 million in 2033, increasing from US$ 105140 million in 2022, with the CAGR of 5.0% during the period of 2023 to 2033. Demand from Diabetes and Infectious Diseases are the major drivers for the industry.
The concentration of the market is relatively high, and the top 10 companies include Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Becton Dickinson, BioMerieux, Sysmex, Hologic, Ortho Clinical Diagnostics, they occupied about 70% of whole market. North America dominates the market which occupied 41.39% of the whole market. Europe, continuing healthcare reforms, will increase the demand. China is going to be a major player in the future, who occupied 15.74% of the whole market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global In-Vitro Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Roche
Abbott
Danaher
Siemens Healthineers
Thermo Fisher Scientific
Sysmex
BioMerieux
Ortho Clinical Diagnostics
Becton Dickinson
Bio-Rad Laboratories
Hologic
LifeScan
Qiagen
Wuhan Easy Diagnosis
Wondfo
KHB
Hotgen
Mindray
Sinocare
Getein Biotech
Segment by Type
Tissue Diagnostics
Professional Diagnostic
Molecular Diagnostic
Diabetes Monitoring
Other
Segment by Application
Diabetes
Infectious Diseases
Oncology
Cardiology
HIV
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the In-Vitro Diagnostics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, In-Vitro Diagnostics introduction, etc. In-Vitro Diagnostics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of In-Vitro Diagnostics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.